Oncternal Therapeutics, Inc.
ONCTCIK 0001260990 · Every Form 4 filed by insiders at this issuer.
Filings
12
Latest Feb 27, 2024
Unique insiders
7
Showing
12 of 12
Page 1
Top insiders
Most active reporters at Oncternal Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| BREITMEYER JAMES B | OfficerDirector | 2 |
| Krishnan Rajesh | Officer | 2 |
| Leavitt Chase C. | Officer | 2 |
| VINCENT RICHARD G | Officer | 2 |
| Yazji Salim | Officer | 2 |
| HALE DAVID F | Director | 1 |
| Wills Robert James | Director | 1 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Feb 27, 2024 | Wills Robert James Director | S | 980 | $9.04 | $8,859 | |
| Feb 27, 2024 | HALE DAVID F Director | P | 714 | $9.04 | $6,455 | |
| Feb 15, 2024 | VINCENT RICHARD G Chief Financial Officer | Holdings only | — | — | — | |
| Feb 15, 2024 | Yazji Salim Chief Medical Officer | Holdings only | — | — | — | |
| Feb 15, 2024 | Krishnan Rajesh CTO/CSO | Holdings only | — | — | — | |
| Feb 15, 2024 | Leavitt Chase C. General Counsel/Secretary | Holdings only | — | — | — | |
| Feb 15, 2024 | BREITMEYER JAMES B Chief Executive Officer · Director | Holdings only | — | — | — | |
| Jan 5, 2024 | BREITMEYER JAMES B Chief Executive Officer · Director | F | 50,955 | $0.4961 | $25,279 | |
| Jan 5, 2024 | Leavitt Chase C. General Counsel/Secretary | F | 11,838 | $0.4961 | $5,873 | |
| Jan 5, 2024 | VINCENT RICHARD G Chief Financial Officer | F | 8,868 | $0.4961 | $4,399 | |
| Jan 5, 2024 | Yazji Salim Chief Medical Officer | F | 19,742 | $0.4961 | $9,794 | |
| Jan 5, 2024 | Krishnan Rajesh Chief Technical Officer | F | 11,838 | $0.4961 | $5,873 |
Showing 1–12 of 12
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.